1. Aoyama, T., Ino, Y., Ozeki, M., Oda, M., Sato, T., Koshiyama, Y., Suzuki, S. & Fujita, M. (1984) Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments. Jpn. J. Pharmacol., 35, 203-227.
2. Bray, M., Hatfill, S., Hensley, L. & Huggins, J.W. (2001) Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus. J. Comp. Pathol., 125, 243-253.
3. Centers for Disease Control and Prevention (2015) Ebola virus disease (EVD) information for clinicians in U.S. healthcare settings. http://www.cdc.gov/vhf/ebola/hcp/clinician-information-us-healthcare-settings.html [Accessed: January 30, 2015].
4. Chandran, K., Sullivan, N.J., Felbor, U., Whelan, S.P. & Cunningham, J.M. (2005) Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science, 308, 1643-1645.
5. Feldmann, H., Sanchez, A. & Geisbert, T.W. (2013) Filoviridae: Marburg and Ebola viruses. Chapter 32. In Fields Virology, 6th ed., edited by Knipe, D.M. & Howley, P.M. Lippincott Williams & Wilkins, Philadelphia, PA, pp. 923-956.